Subtopic Deep Dive
Pediatric Thyroid Carcinoma
Research Guide
What is Pediatric Thyroid Carcinoma?
Pediatric Thyroid Carcinoma refers to differentiated thyroid cancer, primarily papillary and follicular types, occurring in children and often linked to congenital head and neck anomalies with advanced presentation at diagnosis compared to adults.
This rare malignancy shows excellent prognosis despite higher recurrence risks and advanced staging in pediatric patients (Rivkees et al., 2011, 225 citations). Key diagnostic tools include Bethesda cytopathology, TI-RADS ultrasound, and EU-TIRADS/ACR-TIRADS for risk stratification (Tuli et al., 2022; Hess et al., 2023). Over 10 papers from 2011-2024 detail surgical approaches, radioactive iodine therapy, and cytomorphologic features in DICER1 mutations.
Why It Matters
Pediatric Thyroid Carcinoma guides age-specific surgical and adjuvant therapies, improving 95%+ survival rates despite elevated recurrence (Rivkees et al., 2011). TI-RADS systems like EU-TIRADS and ACR-TIRADS enhance malignancy prediction in children, reducing unnecessary biopsies (Tuli et al., 2022, 14 citations; Hess et al., 2023, 11 citations). Follicular variant papillary thyroid carcinoma studies support lobectomy over total thyroidectomy for low-risk cases, minimizing complications (Samuels et al., 2018, 24 citations). Echogenic foci patterns on ultrasound correlate with histopathology, aiding preoperative assessment (Toslak et al., 2017, 11 citations).
Key Research Challenges
Higher Malignancy Rate
Pediatric thyroid nodules have lower prevalence but 5-10x higher malignancy risk than adults, complicating triage (Tuli et al., 2022). EU-TIRADS and ACR-TIRADS show variable performance in children, with ACR-TIRADS better predicting malignancy (Hess et al., 2023).
Advanced Staging at Diagnosis
Differentiated thyroid cancer presents at more advanced stages in children, increasing recurrence despite excellent survival (Rivkees et al., 2011). Surgical and radioactive iodine approaches must balance efficacy with long-term pediatric risks.
DICER1-Associated Cytomorphology
DICER1 mutations link to unique thyroid lesions requiring cytology-histopathology correlation for diagnosis (Darbinyan et al., 2020, 23 citations). Distinguishing follicular variant papillary carcinoma demands strict criteria to assess bilateral disease and metastasis risk (Samuels et al., 2018).
Essential Papers
The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy
Scott A. Rivkees, Ernest L. Mazzaferri, Frederik A. Verburg et al. · 2011 · Endocrine Reviews · 225 citations
Pediatric thyroid cancer is a rare disease with an excellent prognosis. Compared with adults, epithelial-derived differentiated thyroid cancer (DTC), which includes papillary and follicular thyroid...
Approach to Thyroid Nodules: Diagnosis and Treatment
Aram H AlSaedi, Dalia S Almalki, Reem M ElKady · 2024 · Cureus · 27 citations
Thyroid nodules (TNs) are prevalent and found in up to 50% of individuals. While most TNs are benign, some can be malignant. The evaluation of TNs is crucial to rule out malignancy and identify tho...
Characteristics of Follicular Variant Papillary Thyroid Carcinoma in a Pediatric Cohort
Stephanie Samuels, Lea F. Surrey, Colin P. Hawkes et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism · 24 citations
When strictly defined, FVPTC in pediatric patients has a low risk for bilateral disease and metastasis. Prospective studies are needed to confirm whether lobectomy with surveillance is sufficient t...
2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules
Young Joo Park, Eun Kyung Lee, Young Shin Song et al. · 2023 · International Journal of Thyroidology · 24 citations
Young Joo Park, Eun Kyung Lee, Young Shin Song, Soo Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye L...
Cytomorphologic features of thyroid disease in patients with <i>DICER1</i> mutations: A report of cytology–histopathology correlation in 7 patients
Armine Darbinyan, Raffaella Morotti, Guoping Cai et al. · 2020 · Cancer Cytopathology · 23 citations
Background Germline and somatic mutations of DICER1 have been identified in various types of neoplastic lesions, with germline DICER1 mutation being linked to autosomal dominant hereditary pleiotro...
Management of Thyroid Nodules
Mehmet Uludağ · 2023 · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · 17 citations
Thyroid nodules are common and the prevalence varies between 4 and 7% by palpation and 19-68% by high-resolution USG. Most thyroid nodules are benign, and the malignancy rate varies between 7 and 1...
Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules
Gerdi Tuli, Jessica Munarin, Mariapia Scollo et al. · 2022 · Frontiers in Endocrinology · 14 citations
Background Pediatric thyroid nodules have a lower prevalence but a higher rate of malignancy (ROM) than those in adults. Ultrasound features suspected of malignancy lead to fine needle aspiration b...
Reading Guide
Foundational Papers
Start with Rivkees et al. (2011, 225 citations) for core surgical and RAI therapy principles in pediatric DTC, as it establishes advanced staging and prognosis benchmarks.
Recent Advances
Study Hess et al. (2023) for ACR-TIRADS performance and Tuli et al. (2022) for EU-TIRADS in children, plus Samuels et al. (2018) on FVPTC risks.
Core Methods
Bethesda System cytology, ACR-TIRADS/EU-TIRADS ultrasound scoring, FNAB with histopathology correlation, radioactive iodine post-surgery (Hess et al., 2023; Rivkees et al., 2011).
How PapersFlow Helps You Research Pediatric Thyroid Carcinoma
Discover & Search
Research Agent uses searchPapers and exaSearch to find 225-citation Rivkees et al. (2011) on pediatric DTC treatment, then citationGraph reveals 10+ related works on TI-RADS like Tuli et al. (2022) and Hess et al. (2023), while findSimilarPapers uncovers ultrasound echogenic foci studies (Toslak et al., 2017).
Analyze & Verify
Analysis Agent applies readPaperContent to extract Bethesda and TI-RADS data from Hess et al. (2023), verifies ROM predictions via verifyResponse (CoVe) against pediatric cohorts, and uses runPythonAnalysis for statistical comparison of EU-TIRADS vs. ACR-TIRADS sensitivity (Tuli et al., 2022), with GRADE grading for evidence quality on surgical outcomes.
Synthesize & Write
Synthesis Agent detects gaps in pediatric FVPTC lobectomy data (Samuels et al., 2018), flags contradictions in TIRADS performance across studies, and uses exportMermaid for risk stratification flowcharts; Writing Agent employs latexEditText, latexSyncCitations for Rivkees et al. (2011), and latexCompile for protocol manuscripts.
Use Cases
"Compare ACR-TIRADS vs EU-TIRADS sensitivity in pediatric thyroid nodules ROM."
Research Agent → searchPapers(exaSearch 'pediatric TIRADS') → Analysis Agent → runPythonAnalysis(pandas on Hess 2023 + Tuli 2022 data) → outputs sensitivity ROC curves and GRADE-verified table.
"Draft LaTeX review on pediatric DTC surgical approaches."
Synthesis Agent → gap detection(Rivkees 2011 gaps) → Writing Agent → latexEditText + latexSyncCitations(10 papers) → latexCompile → outputs compiled PDF with citations.
"Find code for pediatric thyroid ultrasound analysis from recent papers."
Research Agent → citationGraph(Toslak 2017) → Code Discovery(paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → outputs echogenic foci segmentation Python scripts.
Automated Workflows
Deep Research workflow scans 50+ OpenAlex papers on 'pediatric thyroid carcinoma TIRADS', chains searchPapers → citationGraph → structured report with GRADE scores on Rivkees (2011). DeepScan applies 7-step analysis to Hess et al. (2023) TIRADS data: readPaperContent → runPythonAnalysis(ROC stats) → CoVe verification → checkpoint report. Theorizer generates hypotheses on DICER1 cytology patterns from Darbinyan et al. (2020).
Frequently Asked Questions
What defines Pediatric Thyroid Carcinoma?
It is differentiated thyroid cancer (papillary/follicular) in children, presenting at advanced stages with excellent prognosis but high recurrence (Rivkees et al., 2011).
What are key diagnostic methods?
Ultrasound with ACR-TIRADS/EU-TIRADS for risk stratification, Bethesda cytology, and FNAB; ACR-TIRADS excels in pediatric ROM prediction (Hess et al., 2023; Tuli et al., 2022).
What are major papers?
Rivkees et al. (2011, 225 citations) on surgical/RAI therapy; Samuels et al. (2018, 24 citations) on FVPTC; Darbinyan et al. (2020, 23 citations) on DICER1 cytology.
What open problems exist?
Optimizing lobectomy vs. total thyroidectomy for low-risk FVPTC; improving TIRADS in pediatrics; long-term outcomes in DICER1 mutations (Samuels et al., 2018; Hess et al., 2023).
Research Head and Neck Anomalies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pediatric Thyroid Carcinoma with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Head and Neck Anomalies Research Guide